|
1
|
Kamaraj B and Purohit R: Mutational
analysis of oculocutaneous albinism: A compact review. Biomed Res
Int. 2014:9054722014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Summers CG: Albinism: Classification,
clinical characteristics, and recent findings. Optom Vis Sci.
86:659–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gronskov K, Brøndum-Nielsen K, Lorenz B
and Preising MN: Clinical utility gene card for: Oculocutaneous
albinism. Eur J Hum Genet. 22:2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gong Y, Shao C, Zheng H, Chen B and Guo Y:
Study on genetic epidemiology of albinism. Yi Chuan Xue Bao.
21:169–172. 1994.(In Chinese). PubMed/NCBI
|
|
5
|
Wei A, Wang Y, Long Y, Wang Y, Guo X, Zhou
Z, Zhu W, Liu J, Bian X, Lian S and Li W: A comprehensive analysis
reveals mutational spectra and common alleles in Chinese patients
with oculocutaneous albinism. J Invest Dermatol. 130:716–724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grønskov K, Ek J and Brondum-Nielsen K:
Oculocutaneous albinism. Orphanet J Rare Dis. 2:432007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kausar T, Bhatti MA, Ali M, Shaikh RS and
Ahmed ZM: OCA5, a novel locus for non-syndromic oculocutaneous
albinism, maps to chromosome 4q24. Clin Genet. 84:91–93. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deri B, Kanteev M, Goldfeder M, Lecina D,
Guallar V, Adir N and Fishman A: The unravelling of the complex
pattern of tyrosinase inhibition. Sci Rep. 6:349932016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lai X, Soler-Lopez M, Wichers HJ and
Dijkstra BW: Large-scale recombinant expression and purification of
human tyrosinase suitable for structural studies. PLoS One.
11:e01616972016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamaguchi Y and Hearing VJ: Melanocytes
and their diseases. Cold Spring Harb Perspect Med. 4:pii: a017046.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sánchez-Ferrer A, Rodríguez-López JN,
García-Cánovas F and García-Carmona F: Tyrosinase: A comprehensive
review of its mechanism. Biochim Biophys Acta. 1247:1–11. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J, Choy KW, Chan LW, Leung TY, Tam PO,
Chiang SW, Lam DS, Pang CP and Lai TY: Tyrosinase gene (TYR)
mutations in Chinese patients with oculocutaneous albinism type 1.
Clin Exp Ophthalmol. 38:37–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai CH, Tsai FJ, Wu JY, Lin SP, Chang JG,
Yang CF and Lee CC: Insertion/deletion mutations of type I
oculocutaneous albinism in chinese patients from Taiwan. Hum Mutat.
14:5421999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tripathi RK, Strunk KM, Giebel LB, Weleber
RG and Spritz RA: Tyrosinase gene mutations in type I
(tyrosinase-deficient) oculocutaneous albinism define two clusters
of missense substitutions. Am J Med Genet. 43:865–871. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park SK, Lee KH, Park KC, Lee JS, Spritz
RA and Lee ST: Prevalent and novel mutations of the tyrosinase gene
in Korean patients with tyrosinase-deficient oculocutaneous
albinism. Mol Cells. 7:187–191. 1997.PubMed/NCBI
|
|
16
|
Shah SA, Raheem N, Daud S, Mubeen J,
Shaikh AA, Baloch AH, Nadeem A, Tayyab M, Babar ME and Ahmad J:
Mutational spectrum of the TYR and SLC45A2 genes in Pakistani
families with oculocutaneous albinism, and potential founder effect
of missense substitution (p. Arg77Gln) of tyrosinase. Clin Exp
Dermatol. 40:774–780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SH, Chae H, Kim Y and Kim M:
Molecular analysis of Korean patients with oculocutaneous albinism.
Jpn J Ophthalmol. 56:98–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu N, Kong XD, Shi HR, Wu QH and Jiang M:
Tyrosinase gene mutations in the Chinese Han population with OCA1.
Genet Res (Camb). 96:e142014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Breimer LH, Winder AF, Jay B and Jay M:
Initiation codon mutation of the tyrosinase gene as a cause of
human albinism. Clin Chim Acta. 227:17–22. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ko JM, Yang JA, Jeong SY and Kim HJ:
Mutation spectrum of the TYR and SLC45A2 genes in patients with
oculocutaneous albinism. Mol Med Rep. 5:943–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
King RA, Pietsch J, Fryer JP, Savage S,
Brott MJ, Russell-Eggitt I, Summers CG and Oetting WS: Tyrosinase
gene mutations in oculocutaneous albinism 1 (OCA1): Definition of
the phenotype. Hum Genet. 113:502–513. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goto M, Sato-Matsumura KC, Sawamura D,
Yokota K, Nakamura H and Shimizu H: Tyrosinase gene analysis in
Japanese patients with oculocutaneous albinism. J Dermatol Sci.
35:215–220. 2004. View Article : Google Scholar : PubMed/NCBI
|
